Improvements in symptoms related to bone metastasis in recipients of Lutetium-177 PSMA-617 for prostate cancer.
Pain improved with Lu-PSMA among patients with symptomatic bone mets at start of therapy.
Related Articles
Prevalence of Rotational Malalignment After Infrapatellar Versus Suprapatellar Intramedullary Nailing of Tibial Shaft Fractures
Up to 30% of patients with a tibial shaft fracture sustain iatrogenic rotational malalignment (RM) after infrapatellar (IP) nailing. Although IP nailing remains the management…
‘Living with an RMD at all stages of life’ – Peter Boyd’s Inspiring Journey
Meet Peter Boyd, a 39 year old father from Dublin. Peter shares his personal journey, navigating life with Fibromyalgia while addressing important aspects of…
Precision Medicine in Nephrology: An Integrative Framework of Multidimensional Data in the Kidney Precision Medicine Project
Chronic kidney disease (CKD) and acute kidney injury (AKI) are heterogeneous syndromes defined clinically by serial measures of kidney function. Each condition possesses strong histopathologic…
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood
Early communication between oncologists and ophthalmologist warranted
Examining Mortality Disparities by Sexual Orientation Among Female Nurses
Extensive evidence documents health disparities for lesbian, gay, and bisexual (LGB) women, including worse physical, mental, and behavioral health than heterosexual women. Sarah McKetta, ScM,…
Abatacept Treatment May Slow Atherosclerosis Progression
Patients receiving abatacept experienced smaller increases in mean IMT, max IMT, and plaque score compared with the csDMARD cohorts.
Bridlington: Town of 35,000 down to just one NHS dentist
Bridlington will soon have only one full-time NHS dentist, forcing people to travel or go private.
BMJ Future Health Home Page
BMJ Future Health is a community for innovation in healthcare. We host events, webinar and podcasts throughout the year.
OBGYN
Linked article: This article is commented on by Tarek El-Toukhy, pp. 898 in this issue. To view this mini commentary visit https://doi.org/10.1111/1471-0528.17778
Dr. B S Ajaikumar, World-renowned Oncologist, Founder and executive chairman of HealthCare Global Enterprises Ltd.(HCG)
Dr. B S Ajaikumar – Celebrated Oncologist & Executive Chairman HCG Cancer Centres. An Indian oncologist and entrepreneur. He is the founder and executive chairman…
